Linked Life Data

6482707

Source:http://linkedlifedata.com/resource/pubmed/id/6482707

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1984-11-2
pubmed:abstractText
The results of therapy of 949 patients with cervical cancer are analysed. Therapy was provided in the form of a concomitant method, 60Co agents with low activity were used in intracavitary irradiation. It has been established that doses of 50-70 Gy ensure high 5-year survival rates of patients with Stage I cervical cancer. In patients with Stage II and Stage III cervical cancer survival rates were the highest within the range of 50-70 Gy. A further increase in the absorbed dose level deteriorated the survival rates of the patients, the frequency of local tumor control was not elevated. It is recommended that optimum dose levels be adhered to even during treatment of patients with disseminated cervical cancer.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0025-8334
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
59-62
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1984
pubmed:articleTitle
[Relation of the effectiveness of radiotherapy of cervix cancer to the magnitude of the absorbed dose].
pubmed:publicationType
Journal Article, Comparative Study, English Abstract